Quick Takeaways
- HARBOURVEST PARTNERS LLC filed SCHEDULE 13G for CAMP4 Therapeutics Corporation Common Stock, par value $0.0001 per share (CAMP).
- Disclosed ownership: 6.3%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"HARBOURVEST PARTNERS LLC disclosed 6.3% ownership in CAMP4 Therapeutics Corporation Common Stock, par value $0.0001 per share (CAMP) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| HarbourVest Partners L.P. | 6.3% | 1,271,948 | 0 | 1,271,948 | By: HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman | Adam Freedman; Chief Compliance Officer | |
| HarbourVest Partners, LLC | 6.3% | 1,271,948 | 0 | 1,271,948 | /s/ Adam Freedman | Adam Freedman; Chief Compliance Officer | |
| SMRS-TOPE LLC | 6.3% | 1,271,948 | 1,271,948 | 0 | By: HVST-TOPE LLC, its Managing Member; HarbourVest Partners L.P., its Manager; HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman | Adam Freedman; Chief Compliance Officer | |
| HVST-TOPE LLC | 6.3% | 1,271,948 | 0 | 1,271,948 | By: HarbourVest Partners L.P., its Manager; HarbourVest Partners, LLC, its General Partner; /s/ Adam Freedman | Adam Freedman; Chief Compliance Officer |